| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| H2N1S2 | Uncharacterized protein; Fragment; | LOC101170911; | NULL | 259 | medaka |
| H2MXE6 | Uncharacterized protein; | LOC101163152; | NULL | 367 | medaka |
| D5MPV6 | Non-classical MHC class I molecule; | Orla-UDA; | NULL | 340 | medaka |
| B5MF69 | 3 beta-hydroxysteroid dehydrogenase/delta-5-delta-4 isomerase; | HSD3B; | NP_001131037.1; | 374 | medaka |
| H2MA51 | Uncharacterized protein; | LOC101169002; | NULL | 354 | medaka |
| H2N227 | Uncharacterized protein; | LOC101172885; | XP_004086540.1; | 220 | medaka |
| H2LVK1 | Uncharacterized protein; | LOC101174603; | NULL | 227 | medaka |
| Q5CB01 | Beta3-glucuronyltransferase; EC 2.4.1.135; | b3gat1; | NP_001156555.1; | 335 | medaka |
| Q5GIS7 | Dmrt1-A; Fragment; | Dmrt1; | NULL | 225 | medaka |
| H2N2C4 | Uncharacterized protein; | LOC101174327; | NULL | 189 | medaka |
| E3WET9 | Cocaine-and amphetamine-regulated transcript ch11; | cart; ch11; | NP_001191711.1; | 107 | medaka |
| Q66NG1 | Putative uncharacterized protein; Fragment; | NULL | NULL | 177 | medaka |
| B3TZA0 | Novel immune-type receptor 6 isoform 1; | NITR6; | NP_001131066.1; | 285 | medaka |
| H2LMJ9 | Uncharacterized protein; Fragment; | NULL | NULL | 150 | medaka |
| H2M7Q3 | Uncharacterized protein; Fragment; | TACC2; | NULL | 975 | medaka |
| H2LUN5 | Uncharacterized protein; Fragment; | ACOT11; (2; of; 2); | NULL | 318 | medaka |
| Q90ZJ2 | TAP2 protein; Fragment; | TAP2; | NULL | 187 | medaka |
| H2LUW0 | Uncharacterized protein; | LOC101156064; | NULL | 289 | medaka |
| H2M1H5 | Uncharacterized protein; | LOC101158029; | NULL | 158 | medaka |
| H2LMR1 | Uncharacterized protein; Fragment; | LOC101165402; | NULL | 457 | medaka |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |